Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.

Huntington Ingalls Industries (HII) reports $3.1B Q2 revenue, backlog at $56.9B, with enhanced free cash flow guidance.

Huntington Ingalls Industries Inc (HII) reports a 3.5% revenue increase and significant contract awards, while navigating ...

Antero updated its full-year NGL price guidance slightly downward, attributing the revision to Q2 actuals impacted by inventory adjustments, but continues to expect premiums in the second half of the ...

Investing.com -- Teleperformance (EPA: TEPRF) shares plunged more than 16% on Friday after the company cut its full-year revenue outlook, reported weaker-than-expected margins and missed earnings ...